| Product NDC: | 43063-113 |
| Proprietary Name: | LEVAQUIN |
| Non Proprietary Name: | levofloxacin |
| Active Ingredient(s): | 500 mg/1 & nbsp; levofloxacin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 43063-113 |
| Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020634 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19961220 |
| Package NDC: | 43063-113-30 |
| Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE (43063-113-30) |
| NDC Code | 43063-113-30 |
| Proprietary Name | LEVAQUIN |
| Package Description | 30 TABLET, FILM COATED in 1 BOTTLE (43063-113-30) |
| Product NDC | 43063-113 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | levofloxacin |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 19961220 |
| Marketing Category Name | NDA |
| Labeler Name | PD-Rx Pharmaceuticals, Inc. |
| Substance Name | LEVOFLOXACIN |
| Strength Number | 500 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |